Emzumab 150mg Injection is a monoclonal antibody. It is used in the treatment of moderate to severe asthma in both adults and children. It eases the symptoms of asthma such as wheezing, breathlessness, tightness in your chest, and coughing.

Emzumab 150mg Injection is given as an injection under the supervision of a doctor. The first three dose of medicine is given by the doctor. Your doctor will explain to you the best way to inject the medicine so that you can inject your medicine at home. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you even if you feel better.

The most common side effects of this medicine include joint pain, pain (general), fatigue, dizziness, fracture, itching, dermatitis, upper abdominal pain, nasopharyngitis, headache, and ear pain. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Remember, it does not prevent you from a sudden attack, hence always carry your emergency inhaler with you.

Before taking this medicine if you have liver or kidney disease, or if you are pregnant or planning pregnancy. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. In general, alcohol is not recommended while on treatment with this medicine.

There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Uses of Emzumab Injection

Asthma

Benefits of Emzumab Injection

In Asthma

Emzumab 150mg Injection is used to treat the symptoms of asthma such as tightness in your chest, wheezing, breathlessness and coughing. This means you can carry out your daily activities more easily and more confidently. It may take a few weeks for this medicine to show full effects. It is given as an injection by a doctor or nurse and should not be self-administered. Taking this medicine enables you to live your life more freely without worrying so much about things that set off your symptoms.

Side effects of Emzumab Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Emzumab

Joint pain
Pain
Fatigue
Dizziness
Fracture
Itching
Dermatitis
Upper abdominal pain
Nasopharyngitis (inflammation of the throat and nasal passages)
Ear pain

How to use Emzumab Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Safety advice

Alcohol

SAFE

Consuming alcohol with Emzumab 150mg Injection does not cause any harmful side effects.

Pregnancy

SAFE IF PRESCRIBED

Emzumab 150mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

CONSULT YOUR DOCTOR

Emzumab 150mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

SAFE

Emzumab 150mg Injection does not usually affect your ability to drive.

Kidney

SAFE IF PRESCRIBED

Emzumab 150mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Emzumab 150mg Injection may not be needed in these patients. Please consult your doctor.

Liver

SAFE IF PRESCRIBED

Emzumab 150mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Emzumab 150mg Injection may not be needed in these patients. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Emzumab 150mg Injection

₹10500.0/Injection

Bolstran 150mg Injection

Cipla Ltd

₹10500/injection

same price

Xolair 150mg Injection

Novartis India Ltd

₹32590/injection

210% costlier

Xolair 150mg Injection

Novartis India Ltd

₹32590/injection

210% costlier

Omalirel Injection

Reliance Life Sciences

₹13145/injection

25% costlier

Quick tips

Emzumab 150mg Injection is used for the treatment of moderate to severe asthma.
Seek immediate medical help if you experience symptoms like wheezing, shortness of breath, cough, chest tightness, swelling of the throat or tongue, or trouble breathing.
Inform your doctor immediately if your asthma remains uncontrolled or worsens after initiation of treatment.
Inform your doctor if you have any other allergies (such as food allergies or seasonal allergies).
Let your doctor know if you are or planning to become pregnant or breastfeeding.

Fact Box

Chemical Class

Monoclonal antibody (mAb)

Habit Forming

Therapeutic Class

RESPIRATORY

Action Class

Anti IgE monoclonal antibodies

Patient concerns

I am having asthama & need rotahealer sometime. how to reduce. I am swimming in the morning for one month. kindly advice.

Dr. Anshum Aneja Arora

Pulmonology

read more about asthma at: www.arohealth.com/bronchial asthma

Dry scaling Psoriasis (10 years); asthma 3 years.; obesity I have been on folitrax 7.5 mg x 2 once a week for the last 8 years. I also take folvite 50 daily. The breathing difficulty is recent. I am on seroflo inhaler twice a day and tiate once a day. There is no change in the psoriasis but the asthma is getting worse.

Dr. Atul Jain

Dermatology

You should visit md medicine for asthmaNo idea about asthma

Related lab tests

Absolute Eosinophil Count

Complete Blood Count

Related ayurvedic ingredients

Kalonji

Top Physicians

4.3 ★

4.6 ★

4.1 ★

4.2 ★

4.1 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Boushey HA. Drugs Used in Asthma. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 350.
Barnes PJ. Pulmonary Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1054.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1019-20.
Omalizumab. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2003 [revised Jul. 2016]. [Accessed 1 Apr. 2019] (online) Available from:
Medscape. Omalizumab. [Accessed 01 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:

Marketer details

Name: Cipla Ltd

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.